Angiotensin II-mediated protein kinase D activation stimulates aldosterone and cortisol secretion in H295R human adrenocortical cells

Endocrinology

Volumn 147, Issue 12, 2006, Pages 6046-6055

  Romero, Damian G ^a,b   Welsh, Bronwyn L ^b   Gomez Sanchez, Elise P ^a,b   Yanes, Licy L ^a,b   Rilli, Silvia ^b   Gomez Sanchez, Celso E ^a,b  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ALDOSTERONE SYNTHASE; ANGIOTENSIN II; HYDROCORTISONE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; PROTEIN KINASE D; SERINE; STEROID 11BETA MONOOXYGENASE; THREONINE;

ADRENAL CORTEX CELL; ALDOSTERONE RELEASE; ARTICLE; CELL FUNCTION; CELL METABOLISM; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HYDROCORTISONE RELEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE; STEROIDOGENESIS;

ADRENAL CORTEX; ALDOSTERONE; ANGIOTENSIN II; CELLS, CULTURED; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; HYDROCORTISONE; PHOSPHORYLATION; PROTEIN KINASE C; PROTEIN KINASE C-EPSILON; PROTEIN KINASES; STEROIDS; TRANSFECTION;

EID: 33751536348     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2006-0794     Document Type: Article

References (54)

1. +-induced aldosterone secretion from human adrenocortical NCI-H295 cells. Hypertension 33:1025-1030
2. Vinson GP, Ho MM 1998 The adrenal renin/angiotensin system in the rat. Horm Metab Res 30:355-359
3. Ehrhart-Bornstein M, Hinson JP, Bornstein SR, Scherbaum WA, Vinson GP 1998 Intraadrenal interactions in the regulation of adrenocortical steroidogenesis. Endocr Rev 19:101-143
4. Mulrow PJ 1998 Renin-angiotensin system in the adrenal. Horm Metab Res 30:346-349
5. Barrett PQ, Bollag WB, Isales CM, McCarthy RT, Rasmussen H 1989 Role of calcium in angiotensin II-mediated aldosterone secretion. Endocr Rev 10:496-518
6. Ganguly A, Davis JS 1994 Role of calcium and other mediators in aldosterone secretion from the adrenal glomerulosa cells. Pharmacol Rev 46:417-447
7. Spat A, Hunyady L 2004 Control of aldosterone secretion: a model for convergence in cellular signaling pathways. Physiol Rev 84:489-539
8. Parker PJ, Murray-Rust J 2004 PKC at a glance. J Cell Sci 117:131-132
9. Bird IM, Hanley NA, Word RA, Mathis JM, McCarthy JL, Mason JI, Rainey WE 1993 Human NCI-H295 adrenocortical carcinoma cells: a model for angiotensin-II-responsive aldosterone secretion. Endocrinology 133:1555-1561
10. Rainey WE, Saner K, Schimmer BP 2004 Adrenocortical cell lines. Mol Cell Endocrinol 228:23-38
11. Lint JV, Rykx A, Vantus T, Vandenheede JR 2002 Getting to know protein kinase D. Int J Biochem Cell Biol 34:577-581
12. Van Lint J, Rykx A, Maeda Y, Vantus T, Sturany S, Malhotra V, Vandenheede JR, Seufferlein T 2002 Protein kinase D: an intracellular traffic regulator on the move. Trends Cell Biol 12:193-200
13. Bollag WB, Dodd ME, Shapiro BA 2004 Protein kinase D and keratinocyte proliferation. Drug News Perspect 17:117-126
14. Rykx A, De Kimpe L, Mikhalap S, Vantus T, Seufferlein T, Vandenheede JR, Van Lint J 2003 Protein kinase D: a family affair. FEBS Lett 546:81-86
15. Rozengurt E, Rey O, Waldron RT 2005 Protein kinase D signaling. J Biol Chem 280:13205-13208
16. Wang QJ 2006 PKD at the crossroads of DAG and PKC signaling. Trends Pharmacol Sci 27:317-323
17. Iglesias T, Waldron RT, Rozengurt E 1998 Identification of in vivo phosphorylation sites required for protein kinase D activation. J Biol Chem 273:27662-27667
18. Matthews SA, Rozengurt E, Cantrell D 1999 Characterization of serine 916 as an in vivo autophosphorylation site for protein kinase D/protein kinase Cμ. J Biol Chem 274:26543-26549
19. Romero DG, Plonczynski M, Vergara GR, Gomez-Sanchez EP, Gomez-Sanchez CE 2004 Angiotensin II early regulated genes in H295R human adrenocortical cells. Physiol Genom 19:106-116
20. Pelech S, Sutter C, Zhang H 2003 Kinetworks protein kinase multiblot analysis. Methods Mol Biol 218:99-111
21. Storz P, Doppler H, Toker A 2004 Protein kinase Cä selectively regulates protein kinase D-dependent activation of NF-κB in oxidative stress signaling. Mol Cell Biol 24:2614-2626
22. Sirianni R, Seely JB, Attia G, Stocco DM, Carr BR, Pezzi V, Rainey WE 2002 Liver receptor homologue-1 is expressed in human steroidogenic tissues and activates transcription of genes encoding steroidogenic enzymes. J Endocrinol 174:R13-R17
23. Romero DG, Plonczynski MW, Gomez-Sanchez EP, Yanes LL, Gomez-Sanchez CE 2006 RGS2 is regulated by angiotensin II and functions as a negative feedback of aldosterone production in H295R human adrenocortical cells. Endocrinology 147:3889-3897
24. Gomez-Sanchez CE, Foecking MF, Ferris MW, Chavarri MR, Uribe L, Gomez-Sanchez EP 1987 The production of monoclonal antibodies against aldosterone. Steroids 49:581-587
25. Romero DG, Vergara GR, Zhu Z, Covington GS, Plonczynski MW, Yanes LL, Gomez-Sanchez EP, Gomez-Sanchez CE 2006 Interleukin-8 synthesis, regulation, and steroidogenic role in H295R human adrenocortical cells. Endocrinology 147:891-898
26. Waldron RT, Rey O, Iglesias T, Tugal T, Cantrell D, Rozengurt E 2001 Activation loop Ser744 and Ser748 in protein kinase D are transphosphorylated in vivo. J Biol Chem 276:32606-32615
27. LeHoux JG, Dupuis G, Lefebvre A 2001 Control of CYP11B2 gene expression through differential regulation of its promoter by atypical and conventional protein kinase C isoforms. J Biol Chem 276:8021-8028
28. Gschwendt M, Dieterich S, Rennecke J, Kittstein W, Mueller HJ, Johannes FJ 1996 Inhibition of protein kinase Cμ by various inhibitors. Differentiation from protein kinase C isoenzymes. FEBS Lett 392:77-80
29. Waldron RT, Rozengurt E 2003 Protein kinase C phosphorylates protein kinase D activation loop Ser744 and Ser748 and releases autoinhibition by the pleckstrin homology domain. J Biol Chem 278:154-163
30. Toullec D, Pianetti P, Coste H, Bellevergue P, Grand-Perret T, Ajakane M, Baudet V, Boissin P, Boursier E, Loriolle F, Duhamel L, Charon D, Kirilovsky J 1991 The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem 266:15771-15781
31. Martiny-Baron G, Kazanietz MG, Mischak H, Blumberg PM, Kochs G, Hug H, Marme D, Schachtele C 1993 Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976. J Biol Chem 268:9194-9197
32. Yeo EJ, Exton JH 1995 Stimulation of phospholipase D by epidermal growth factor requires protein kinase C activation in Swiss 3T3 cells. J Biol Chem 270:3980-3988
33. Wilkinson SE, Parker PJ, Nixon JS 1993 Isoenzyme specificity of bisindolylmaleimides, selective inhibitors of protein kinase C. Biochem J 294:335-337
34. Eichholtz T, de Bont DB, de Widt J, Liskamp RM, Ploegh HL 1993 A myristoylated pseudosubstrate peptide, a novel protein kinase C inhibitor. J Biol Chem 268:1982-1986
35. Gschwendt M, Muller HJ, Kielbassa K, Zang R, Kittstein W, Rincke G, Marks F 1994 Rottlerin, a novel protein kinase inhibitor. Biochem Biophys Res Commun 199:93-98
36. LeHoux JG, Lefebvre A 2006 Novel protein kinase C-ε inhibits human CYP11B2 gene expression through ERK1/2 signalling pathway and JunB. J Mol Endocrinol 36:51-64
37. Rey O, Reeve Jr JR, Zhukova E, Sinnett-Smith J, Rozengurt E 2004 G protein-coupled receptor-mediated phosphorylation of the activation loop of protein kinase D: dependence on plasma membrane translocation and protein kinase Cε. J Biol Chem 279:34361-34372
38. Mochly-Rosen D, Gordon AS 1998 Anchoring proteins for protein kinase C: a means for isozyme selectivity. FASEB J 12:35-42
39. Souroujon MC, Mochly-Rosen D 1998 Peptide modulators of protein-protein interactions in intracellular signaling. Nat Biotechnol 16:919-924
40. Abedi H, Rozengurt E, Zachary I 1998 Rapid activation of the novel serine/threonine protein kinase, protein kinase D by phorbol esters, angiotensin II and PDGF-BB in vascular smooth muscle cells. FEBS Lett 427:209-212
41. Tan M, Xu X, Ohba M, Cui MZ 2004 Angiotensin II-induced protein kinase D activation is regulated by protein kinase Cä and mediated via the angiotensin II type 1 receptor in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 24:2271-2276
42. Chiu T, Rozengurt E 2001 PKD in intestinal epithelial cells: rapid activation by phorbol esters, LPA, and angiotensin through PKC. Am J Physiol Cell Physiol 280:C929-C942
43. Iwata M, Maturana A, Hoshijima M, Tatematsu K, Okajima T, Vandenheede JR, Van Lint J, Tanizawa K, Kuroda S 2005 PKCε-PKD1 signaling complex at Z-discs plays a pivotal role in the cardiac hypertrophy induced by G-protein coupling receptor agonists. Biochem Biophys Res Commun 327:1105-1113
44. Li J, O'Connor KL, Hellmich MR, Greeley Jr GH, Townsend Jr CM, Evers BM 2004 The role of protein kinase D in neurotensin secretion mediated by protein kinase C-α/-ä and Rho/Rho kinase. J Biol Chem 279:28466-28474
45. Wong C, Jin ZG 2005 Protein kinase C-dependent protein kinase D activation modulates ERK signal pathway and endothelial cell proliferation by vascular endothelial growth factor. J Biol Chem 280:33262-33269
46. Tan M, Xu X, Ohba M, Ogawa W, Cui MZ 2003 Thrombin rapidly induces protein kinase D phosphorylation, and protein kinase Cä mediates the activation. J Biol Chem 278:2824-2828
47. Waldron RT, Iglesias T, Rozengurt E 1999 The pleckstrin homology domain of protein kinase D interacts preferentially with the η isoform of protein kinase C. J Biol Chem 274:9224-9230
48. Brandlin I, Eiseler T, Salowsky R, Johannes FJ 2002 Protein kinase Cμ regulation of the JNK pathway is triggered via phosphoinositide-dependent kinase 1 and protein kinase Cε. J Biol Chem 277:45451-45457
49. Natarajan R, Lanting L, Xu L, Nadler J 1994 Role of specific isoforms of protein kinase C in angiotensin II and lipoxygenase action in rat adrenal glomerulosa cells. Mol Cell Endocrinol 101:59-66
50. Moneva MH, Gomez-Sanchez CE 2001 Establishing the diagnosis of primary hyperaldosteronism. Curr Opin Endocrinol Diabetes 8:124-129
51. Young Jr WF 2003 Primary aldosteronism: changing concepts in diagnosis and treatment. Endocrinology 144:2208-2213
52. Mulatero P, Stowasser M, Loh KC, Fardella CE, Gordon RD, Mosso L, Gomez-Sanchez CE, Veglio F, Young Jr WF 2004 Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab 89:1045-1050
53. Rossi GP, Sacchetto A, Pavan E, Palatini P, Graniero GR, Canali C, Pessina AC 1997 Remodeling of the left ventricle in primary aldosteronism due to Conn's adenoma. Circulation 95:1471-1478
54. Tanabe A, Naruse M, Naruse K, Hase M, Yoshimoto T, Tanaka M, Seki T, Demura H 1997 Left ventricular hypertrophy is more prominent in patients with primary aldosteronism than in patients with other types of secondary hypertension. Hypertension Res 20:85-90